Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Kostakoglu

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Hematology|April 8, 2016
The evolving role of response-adapted PET imaging in Hodgkin lymphomaMichael Coyle, Lale Kostakoglu, Andrew M Evens
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 18, 2003
Clinical role of FDG PET in evaluation of cancer patientsLale Kostakoglu, Harry Agress, Stanley J Goldsmith
BMC Medical Imaging|October 22, 2010
Extraperitoneal urine leak after renal transplantation: the role of radionuclide imaging and the value of accompanying SPECT/CT - a case reportHongju Son, Sherif Heiba, Lale Kostakoglu, et al.
World Journal of Nuclear Medicine|February 6, 2018
Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain ImagingKarin Knešaurek, Geoffrey Warnock, Lale Kostakoglu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 17, 2004
PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptakeLale Kostakoglu, Ruth Hardoff, Rosna Mirtcheva, et al.
EJNMMI Physics|August 31, 2018
Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (<sup>90</sup>Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with <sup>90</sup>Y microspheresKarin Knešaurek, Abbas Tuli, Edward Kim, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
European Journal of Radiology|December 12, 2018
Quantitative comparison of pre-therapy <sup>99m</sup>Tc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial radioembolization therapy with <sup>90</sup>Y microspheresKarin Knešaurek, Abbas Tuli, Sara D Pasik, et al.
Nuclear Medicine Communications|December 16, 2016
The ideal dual-isotope imaging combination in evaluating patients with suspected infection of pelvic pressure ulcersSherif I Heiba, Lewen Stempler, Timothy Sullivan, et al.
Clinical Nuclear Medicine|November 22, 2007
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantationBharat Mocherla, Jongho Kim, Sasan Roayaie, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Hematology|April 8, 2016
The evolving role of response-adapted PET imaging in Hodgkin lymphomaMichael Coyle, Lale Kostakoglu, Andrew M Evens
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 18, 2003
Clinical role of FDG PET in evaluation of cancer patientsLale Kostakoglu, Harry Agress, Stanley J Goldsmith
BMC Medical Imaging|October 22, 2010
Extraperitoneal urine leak after renal transplantation: the role of radionuclide imaging and the value of accompanying SPECT/CT - a case reportHongju Son, Sherif Heiba, Lale Kostakoglu, et al.
World Journal of Nuclear Medicine|February 6, 2018
Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain ImagingKarin Knešaurek, Geoffrey Warnock, Lale Kostakoglu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 17, 2004
PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptakeLale Kostakoglu, Ruth Hardoff, Rosna Mirtcheva, et al.
EJNMMI Physics|August 31, 2018
Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (<sup>90</sup>Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with <sup>90</sup>Y microspheresKarin Knešaurek, Abbas Tuli, Edward Kim, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
European Journal of Radiology|December 12, 2018
Quantitative comparison of pre-therapy <sup>99m</sup>Tc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial radioembolization therapy with <sup>90</sup>Y microspheresKarin Knešaurek, Abbas Tuli, Sara D Pasik, et al.
Nuclear Medicine Communications|December 16, 2016
The ideal dual-isotope imaging combination in evaluating patients with suspected infection of pelvic pressure ulcersSherif I Heiba, Lewen Stempler, Timothy Sullivan, et al.
Clinical Nuclear Medicine|November 22, 2007
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantationBharat Mocherla, Jongho Kim, Sasan Roayaie, et al.
Pageof 12